Ameren Illinois Files 8-K for Routine Updates

TL;DR

Ameren Illinois filed a routine 8-K on 6/27/24. No major news.

AI Summary

Ameren Illinois Co. filed an 8-K on June 27, 2024, to report other events and financial statements. The filing primarily serves as an update and does not disclose specific new financial figures or material events beyond routine reporting requirements.

Why It Matters

This filing indicates Ameren Illinois is adhering to its regular reporting schedule with the SEC, providing transparency to investors about its corporate activities.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for other events and financial statements, not indicating any new risks or material changes.

Key Players & Entities

• Ameren Illinois Co (company) — Filer
• Ameren Corp (company) — Parent Company
• 0001104659-24-075482 (accession_number) — Filing Identifier
• 20240627 (date) — Filing Date

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value per share AEE New York St
• $625 million — subsidiary of Ameren Corporation, sold $625 million principal amount of its 5.55% First Mor
• $618.3 m — net offering proceeds of approximately $618.3 million, before expenses, upon closing of

Filing Documents

• tm2417229d5_8k.htm (8-K) — 48KB
• tm2417229d5_ex1-1.htm (EX-1.1) — 214KB
• tm2417229d5_ex4-2.htm (EX-4.2) — 122KB
• tm2417229d5_ex5-1.htm (EX-5.1) — 9KB
• tm2417229d5_ex5-2.htm (EX-5.2) — 9KB
• tm2417229d5_ex1img001.jpg (GRAPHIC) — 7KB
• tm2417229d5_ex5-1img001.jpg (GRAPHIC) — 16KB
• tm2417229d5_ex5-2img001.jpg (GRAPHIC) — 9KB
• tm2417229d5_ex5-2img002.jpg (GRAPHIC) — 1KB
• tm2417229d5_ex5-2img003.jpg (GRAPHIC) — 1KB
• 0001104659-24-075482.txt ( ) — 739KB
• aee-20240627.xsd (EX-101.SCH) — 3KB
• aee-20240627_def.xml (EX-101.DEF) — 26KB
• aee-20240627_lab.xml (EX-101.LAB) — 35KB
• aee-20240627_pre.xml (EX-101.PRE) — 24KB
• tm2417229d5_8k_htm.xml (XML) — 7KB

01 Other Events

ITEM 8.01 Other Events. On June 27, 2024, Ameren Illinois Company ("Ameren Illinois"), a subsidiary of Ameren Corporation, sold $625 million principal amount of its 5.55% First Mortgage Bonds due 2054 (the "Bonds"). The Bonds were offered pursuant to a Registration Statement on Form S-3 (File No. 333-274977-01), which became effective on October 13, 2023, and a Prospectus Supplement dated June 17, 2024, to a Prospectus dated October 13, 2023. Ameren Illinois received net offering proceeds of approximately $618.3 million, before expenses, upon closing of the transaction. This Current Report on Form 8-K is being filed to report as exhibits certain documents in connection with the offering of the Bonds.

01 Financial Statements and Exhibits

ITEM 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Title 1.1 Underwriting Agreement relating to the Bonds, dated June 17, 2024, between Ameren Illinois and the several underwriters named therein, for whom Barclays Capital Inc., MUFG Securities Americas Inc., Scotia Capital (USA) Inc., TD Securities (USA) LLC and Wells Fargo Securities, LLC are acting as representatives. 4.1* General Mortgage Indenture and Deed of Trust, dated as of November 1, 1992, from Ameren Illinois to The Bank of New York Mellon Trust Company, N.A., as successor trustee (1992 Form 10-K, Exhibit 4(cc), File No. 1-3004). 4.2 Supplemental Indenture, dated as of June 1, 2024, by and between Ameren Illinois and The Bank of New York Mellon Trust Company, N.A., as successor trustee, relating to the Bonds. 5.1 Opinion of Stephen C. Lee, Esq., Vice President and Deputy General Counsel of Ameren Illinois, regarding the legality of the Bonds (including consent). 5.2 Opinion of Morgan, Lewis & Bockius LLP regarding the legality of the Bonds (including consent). 104 Cover Page Interactive Data File (formatted as Inline XBRL). * Incorporated by reference as indicated. This combined Form 8-K is being filed separately by Ameren Corporation and Ameren Illinois Company (each a "registrant"). Information contained herein relating to any individual registrant has been filed by such registrant on its own behalf. No registrant makes any representation as to information relating to any other registrant.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, each registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. The signature for each undersigned company shall be deemed to relate only to matters having reference to such company or its subsidiaries. AMEREN CORPORATION (Registrant) By: /s/ Michael L. Moehn Name: Michael L. Moehn Title: Senior Executive Vice President and Chief FinancialOfficer AMEREN ILLINOIS COMPANY (Registrant) By: /s/ Leonard P. Singh Name: Leonard P. Singh Title: Chairman and President Date: June 27, 2024

View Full Filing

View this 8-K filing on SEC EDGAR